TRAX
First Tracks Biotherapeutics Inc
NASDAQ · Healthcare · Biotechnology · US
$36.28
+5.28%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-98.4%
Return on equity
-90.7%
Return on assets
-103.4%
Return on invested capital
0.00x
Asset turnover
-$142.9M
Cash from operations
$4.68
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026